Trial Profile
A Study to Evaluate the Efficacy and Safety of Perampanel in Patients With Partial Epilepsy
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jan 2018
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- Acronyms Fydata
- 18 Feb 2016 New trial record